Company ESSA Pharma Inc Toronto S.E.
Equities
EPI
CA29668H1047
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 23/06/15 |
David Wood
DFI | Director of Finance/CFO | 66 | 30/09/13 |
Peter Virsik
COO | Chief Operating Officer | - | 31/07/16 |
Chief Tech/Sci/R&D Officer | 63 | 14/07/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 04/03/15 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 30/07/19 |
Richard Glickman
CHM | Chairman | 65 | 30/09/10 |
Director/Board Member | 55 | 30/07/19 | |
Scott Requadt
BRD | Director/Board Member | 56 | 13/01/16 |
David Parkinson
CEO | Chief Executive Officer | 73 | 23/06/15 |
Philip Kantoff
BRD | Director/Board Member | 69 | 12/09/22 |
Ann Thorell
BRD | Director/Board Member | 56 | 30/07/19 |
Gary Sollis
BRD | Director/Board Member | 69 | 25/04/12 |
Lauren Merendino
BRD | Director/Board Member | 49 | 05/06/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 44,238,147 | 43,230,993 ( 97.72 %) | 0 | 97.72 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |